Julie Hambleton

Affiliations

  • Director at Springworks Therapeutics Inc. (SWTX), 2025-05-15
  • at Igm Biosciences Inc. (IGMS), 2024-07-29
  • Director at Erasca Inc. (ERAS), 2024-06-21
  • Svp, Chief Medical Officer at Ideaya Biosciences Inc. (IDYA), 2020-02-25
  • Evp & Chief Medical Officer at Five Prime Therapeutics Inc (FPRX), 2015-11-13
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
ERAS $16.00 6,000 $96,000.00 6,000 2021-07-20 Filing
IGMS $18.31 5,000 $91,550.00 5,000 2019-09-18 Filing
FPRX $13.70 64 $876.80 64 2013-09-30 Filing
FPRX $10.75 400 $4,300.00 1,700 2014-08-22 Filing
FPRX $10.10 500 $5,050.00 1,300 2013-11-06 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
SWTX $53.01 13,774 $730,206.57 4,095 2025-02-10 Filing
IGMS $14.00 15,132 $211,848.00 2,000 2024-07-25 Filing
SWTX $42.09 20 $841.81 4,095 2024-06-03 Filing
SWTX $41.49 931 $38,629.42 4,115 2024-06-03 Filing
SWTX $40.57 751 $30,465.44 5,046 2024-06-03 Filing